Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00262600
Other study ID # 1160.26
Secondary ID 2005-003894-26
Status Completed
Phase Phase 3
First received
Last updated
Start date December 2005

Study information

Verified date April 2014
Source Boehringer Ingelheim
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this trial is to demonstrate the efficacy and safety of dabigatran etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism.


Recruitment information / eligibility

Status Completed
Enrollment 18113
Est. completion date
Est. primary completion date April 2009
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria Patients with non-valvular atrial fibrillation (AF), at moderate to high risk of stroke, or systemic embolism with at least one additional risk factor (i.e. previous ischemic stroke, TIA, or systemic embolism, left ventricular dysfunction, age >=75 years, age >=65 with either diabetes mellitus, history of coronary artery disease or hypertension)

Exclusion criteria

1. Prosthetic heart valves requiring anticoagulation per se, or hemodynamically relevant valve disease that is expected to require surgical intervention during the course of the study

2. Severe, disabling stroke within the previous 6 months, or any stroke within the previous 14 days

3. Conditions associated with an increased risk of bleeding

4. Contraindication to warfarin treatment

5. Reversible causes of atrial fibrillation (e.g., cardiac surgery, pulmonary embolism, untreated hyperthyroidism).

6. Plan to perform a pulmonary vein ablation or surgery for cure of the AF

7. Severe renal impairment (estimated creatinine clearance <=30 mL/min)

8. Active infective endocarditis

9. Active liver disease

10. Women who are pregnant, lactating, or of childbearing potential who refuse to use a medically acceptable form of contraception throughout the study

11. Anaemia (haemoglobin <100g/L) or thrombocytopenia (platelet count <100 x 109/L)

12. Patients who have developed transaminase elevations upon exposure to ximelagatran

13. Patients who have received an investigational drug in the past 30 days or are participating in another drug study

14. Patients considered unreliable by the investigator concerning the requirements for follow-up during the study and/or compliance with study drug administration, has a life expectancy less than the expected duration of the trial due to concomitant disease, or has any condition which in the opinion of the investigator, would not allow safe participation in the study (e.g., drug addiction, alcohol abuse)

15. Any known hypersensitivity to galactose if the warfarin used contains galactose.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
warfarin
once a day
Dabigatran dose 1
twice daily
Dabigatran dose 2
twice a day

Locations

Country Name City State
Argentina 1160.26.0523 Boehringer Ingelheim Investigational Site Bahía Blanca
Argentina 1160.26.0524 Boehringer Ingelheim Investigational Site Capital Federal
Argentina 1160.26.0533 Boehringer Ingelheim Investigational Site Capital Federal
Argentina 1160.26.0526 Boehringer Ingelheim Investigational Site Cipolletti
Argentina 1160.26.0531 Boehringer Ingelheim Investigational Site Córdoba
Argentina 1160.26.0529 Boehringer Ingelheim Investigational Site Coronel Suárez
Argentina 1160.26.0530 Boehringer Ingelheim Investigational Site La Plata
Argentina 1160.26.0527 Boehringer Ingelheim Investigational Site Mar del Plata
Argentina 1160.26.0532 Boehringer Ingelheim Investigational Site Mar del Plata
Argentina 1160.26.0525 Boehringer Ingelheim Investigational Site Quilmes
Argentina 1160.26.0521 Boehringer Ingelheim Investigational Site Rosario
Argentina 1160.26.0528 Boehringer Ingelheim Investigational Site Salta
Argentina 1160.26.0522 Boehringer Ingelheim Investigational Site Santa Fe
Australia 1160.26.0509 Boehringer Ingelheim Investigational Site Ashford South Australia
Australia 1160.26.0504 Boehringer Ingelheim Investigational Site Box Hill Victoria
Australia 1160.26.0508 Boehringer Ingelheim Investigational Site Coffs Harbour New South Wales
Australia 1160.26.0501 Boehringer Ingelheim Investigational Site Geelong Victoria
Australia 1160.26.0510 Boehringer Ingelheim Investigational Site Gosford New South Wales
Australia 1160.26.0505 Boehringer Ingelheim Investigational Site Herston Queensland
Australia 1160.26.0507 Boehringer Ingelheim Investigational Site Launceston Tasmania
Australia 1160.26.0506 Boehringer Ingelheim Investigational Site Milton Queensland
Australia 1160.26.0502 Boehringer Ingelheim Investigational Site Parkville Victoria
Australia 1160.26.0503 Boehringer Ingelheim Investigational Site Prahran Victoria
Austria 1160.26.0543 Boehringer Ingelheim Investigational Site Graz
Austria 1160.26.0549 Boehringer Ingelheim Investigational Site Linz
Austria 1160.26.0546 Boehringer Ingelheim Investigational Site Wels
Austria 1160.26.0541 Boehringer Ingelheim Investigational Site Wien
Austria 1160.26.0542 Boehringer Ingelheim Investigational Site Wien
Austria 1160.26.0544 Boehringer Ingelheim Investigational Site Wien
Austria 1160.26.0545 Boehringer Ingelheim Investigational Site Wien
Austria 1160.26.0547 Boehringer Ingelheim Investigational Site Wien
Austria 1160.26.0548 Boehringer Ingelheim Investigational Site Wien
Austria 1160.26.0550 Boehringer Ingelheim Investigational Site Wr. Neustadt
Belgium 1160.26.0564 Boehringer Ingelheim Investigational Site Aalst
Belgium 1160.26.0573 Boehringer Ingelheim Investigational Site Antwerpen
Belgium 1160.26.0575 Boehringer Ingelheim Investigational Site Antwerpen
Belgium 1160.26.0572 Boehringer Ingelheim Investigational Site Brasschaat
Belgium 1160.26.0577 Boehringer Ingelheim Investigational Site Brugge
Belgium 1160.26.0571 Boehringer Ingelheim Investigational Site Brussels
Belgium 1160.26.0581 Boehringer Ingelheim Investigational Site Bruxelles
Belgium 1160.26.0585 Boehringer Ingelheim Investigational Site Bruxelles
Belgium 1160.26.0586 Boehringer Ingelheim Investigational Site Bruxelles
Belgium 1160.26.0563 Boehringer Ingelheim Investigational Site Edegem
Belgium 1160.26.0578 Boehringer Ingelheim Investigational Site Genk
Belgium 1160.26.0587 Boehringer Ingelheim Investigational Site Genk
Belgium 1160.26.0574 Boehringer Ingelheim Investigational Site Gent
Belgium 1160.26.0588 Boehringer Ingelheim Investigational Site Gilly
Belgium 1160.26.0580 Boehringer Ingelheim Investigational Site Haine-St.-Paul
Belgium 1160.26.0568 Boehringer Ingelheim Investigational Site Hasselt
Belgium 1160.26.0569 Boehringer Ingelheim Investigational Site Kortrijk
Belgium 1160.26.0561 Boehringer Ingelheim Investigational Site Leuven
Belgium 1160.26.0579 Boehringer Ingelheim Investigational Site Liège
Belgium 1160.26.0583 Boehringer Ingelheim Investigational Site Liège
Belgium 1160.26.0589 Boehringer Ingelheim Investigational Site Mol
Belgium 1160.26.0567 Boehringer Ingelheim Investigational Site Oostende
Belgium 1160.26.0570 Boehringer Ingelheim Investigational Site Roeselare
Belgium 1160.26.0566 Boehringer Ingelheim Investigational Site Tienen
Belgium 1160.26.0562 Boehringer Ingelheim Investigational Site Turnhout
Brazil 1160.26.550648 Boehringer Ingelheim Investigational Site Belo Horizonte
Brazil 1160.26.550654 Boehringer Ingelheim Investigational Site Blumenau
Brazil 1160.26.550644 Boehringer Ingelheim Investigational Site Campinas
Brazil 1160.26.550650 Boehringer Ingelheim Investigational Site Curitiba
Brazil 1160.26.550651 Boehringer Ingelheim Investigational Site Curitiba
Brazil 1160.26.550653 Boehringer Ingelheim Investigational Site Curitiba
Brazil 1160.26.550652 Boehringer Ingelheim Investigational Site Goiania
Brazil 1160.26.550645 Boehringer Ingelheim Investigational Site Marília
Brazil 1160.26.550646 Boehringer Ingelheim Investigational Site São José do Rio Preto
Brazil 1160.26.550647 Boehringer Ingelheim Investigational Site São José do Rio Preto
Brazil 1160.26.550641 Boehringer Ingelheim Investigational Site São Paulo
Brazil 1160.26.550642 Boehringer Ingelheim Investigational Site São Paulo
Brazil 1160.26.550643 Boehringer Ingelheim Investigational Site São Paulo
Brazil 1160.26.550649 Boehringer Ingelheim Investigational Site Uberaba
Bulgaria 1160.26.0620 Boehringer Ingelheim Investigational Site Pleven
Bulgaria 1160.26.0611 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0612 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0613 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0614 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0615 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0616 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0617 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0618 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0622 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0623 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0624 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0625 Boehringer Ingelheim Investigational Site Sofia
Bulgaria 1160.26.0626 Boehringer Ingelheim Investigational Site Stara Zagora
Bulgaria 1160.26.0621 Boehringer Ingelheim Investigational Site Varna
Canada 1160.26.0679 Boehringer Ingelheim Investigational Site Ajax Ontario
Canada 1160.26.0676 Boehringer Ingelheim Investigational Site Antigonish Nova Scotia
Canada 1160.26.0707 Boehringer Ingelheim Investigational Site Bay Roberts Newfoundland and Labrador
Canada 1160.26.0677 Boehringer Ingelheim Investigational Site Brampton Ontario
Canada 1160.26.0674 Boehringer Ingelheim Investigational Site Burlington Ontario
Canada 1160.26.0694 Boehringer Ingelheim Investigational Site Calgary Alberta
Canada 1160.26.0696 Boehringer Ingelheim Investigational Site Calgary Alberta
Canada 1160.26.0702 Boehringer Ingelheim Investigational Site Cambridge Ontario
Canada 1160.26.0720 Boehringer Ingelheim Investigational Site Cambridge Ontario
Canada 1160.26.0680 Boehringer Ingelheim Investigational Site Coquitlam British Columbia
Canada 1160.26.0712 Boehringer Ingelheim Investigational Site Coquitlam British Columbia
Canada 1160.26.0671 Clinical Research & Diagnostic Solutions Inc. Etobicoke Ontario
Canada 1160.26.0692 Boehringer Ingelheim Investigational Site Grimsby Ontario
Canada 1160.26.0703 Boehringer Ingelheim Investigational Site Halifax Nova Scotia
Canada 1160.26.0685 Boehringer Ingelheim Investigational Site Hamilton Ontario
Canada 1160.26.0697 Boehringer Ingelheim Investigational Site Hamilton Ontario
Canada 1160.26.0710 Boehringer Ingelheim Investigational Site Hamilton Ontario
Canada 1160.26.0719 Boehringer Ingelheim Investigational Site Hamilton Ontario
Canada 1160.26.0721 Boehringer Ingelheim Investigational Site Hamilton Ontario
Canada 1160.26.0706 Boehringer Ingelheim Investigational Site Kelowna British Columbia
Canada 1160.26.0689 Boehringer Ingelheim Investigational Site Kitchener Ontario
Canada 1160.26.0693 Boehringer Ingelheim Investigational Site Longueuil Quebec
Canada 1160.26.0695 Boehringer Ingelheim Investigational Site Mississauga Ontario
Canada 1160.26.0708 Boehringer Ingelheim Investigational Site Mississauga Ontario
Canada 1160.26.0724 Boehringer Ingelheim Investigational Site Mississauga Ontario
Canada 1160.26.0681 Boehringer Ingelheim Investigational Site Montreal Quebec
Canada 1160.26.0683 Boehringer Ingelheim Investigational Site Montreal Quebec
Canada 1160.26.0705 Boehringer Ingelheim Investigational Site Montreal Quebec
Canada 1160.26.0709 Boehringer Ingelheim Investigational Site Montreal Quebec
Canada 1160.26.0716 Boehringer Ingelheim Investigational Site Montreal Quebec
Canada 1160.26.0725 Boehringer Ingelheim Investigational Site Nanaimo British Columbia
Canada 1160.26.0691 Boehringer Ingelheim Investigational Site New Westminster British Columbia
Canada 1160.26.0688 Boehringer Ingelheim Investigational Site Newmarket Ontario
Canada 1160.26.0672 Boehringer Ingelheim Investigational Site Oshawa Ontario
Canada 1160.26.0687 Boehringer Ingelheim Investigational Site Ottawa Ontario
Canada 1160.26.0701 Boehringer Ingelheim Investigational Site Portage la Prairie Manitoba
Canada 1160.26.0717 Boehringer Ingelheim Investigational Site Quebec City Quebec
Canada 1160.26.0713 Boehringer Ingelheim Investigational Site Saint George-de-Beauce Quebec
Canada 1160.26.0704 Boehringer Ingelheim Investigational Site Saint Jerome Quebec
Canada 1160.26.0673 Boehringer Ingelheim Investigational Site Saskatoon Saskatchewan
Canada 1160.26.0678 Boehringer Ingelheim Investigational Site Saskatoon Saskatchewan
Canada 1160.26.0723 Boehringer Ingelheim Investigational Site Scarborough Ontario
Canada 1160.26.0699 Boehringer Ingelheim Investigational Site St. Charles-Borromee Quebec
Canada 1160.26.0675 Boehringer Ingelheim Investigational Site St. Hyacinthe Quebec
Canada 1160.26.0700 Boehringer Ingelheim Investigational Site Ste-Foy Quebec
Canada 1160.26.0715 Boehringer Ingelheim Investigational Site Sudbury Ontario
Canada 1160.26.0682 Boehringer Ingelheim Investigational Site Terrebonne (Lachenaie) Quebec
Canada 1160.26.0690 Boehringer Ingelheim Investigational Site Thunder Bay Ontario
Canada 1160.26.0684 Boehringer Ingelheim Investigational Site Toronto Ontario
Canada 1160.26.0718 Boehringer Ingelheim Investigational Site Toronto Ontario
Canada 1160.26.0714 Boehringer Ingelheim Investigational Site Victoria British Columbia
Canada 1160.26.0711 Boehringer Ingelheim Investigational Site Waterloo Ontario
Canada 1160.26.0686 Boehringer Ingelheim Investigational Site Windsor Ontario
Canada 1160.26.0698 Boehringer Ingelheim Investigational Site Winnipeg Manitoba
China 1160.26.0771 Boehringer Ingelheim Investigational Site Beijing
China 1160.26.0772 Boehringer Ingelheim Investigational Site Beijing
China 1160.26.0773 Boehringer Ingelheim Investigational Site Beijing
China 1160.26.0774 Boehringer Ingelheim Investigational Site Beijing
China 1160.26.0775 Boehringer Ingelheim Investigational Site Beijing
China 1160.26.0783 Boehringer Ingelheim Investigational Site Beijing
China 1160.26.0784 Boehringer Ingelheim Investigational Site Hangzhou
China 1160.26.0776 Boehringer Ingelheim Investigational Site Harbin
China 1160.26.0778 Boehringer Ingelheim Investigational Site QingDao
China 1160.26.0781 Boehringer Ingelheim Investigational Site Shanghai
China 1160.26.0782 Boehringer Ingelheim Investigational Site Shanghai
China 1160.26.0777 Boehringer Ingelheim Investigational Site Shenyang
China 1160.26.0780 Boehringer Ingelheim Investigational Site Shijiazhuang
Colombia 1160.26.0801 Boehringer Ingelheim Investigational Site Bogotá
Colombia 1160.26.0802 Boehringer Ingelheim Investigational Site Bogotá
Colombia 1160.26.0803 Boehringer Ingelheim Investigational Site Bogotá
Czechia 1160.26.0815 Boehringer Ingelheim Investigational Site Brno
Czechia 1160.26.0816 Boehringer Ingelheim Investigational Site Brno
Czechia 1160.26.0820 Boehringer Ingelheim Investigational Site Ostrava 1
Czechia 1160.26.0818 Boehringer Ingelheim Investigational Site Pardubice
Czechia 1160.26.0814 Boehringer Ingelheim Investigational Site Plzen-Bory
Czechia 1160.26.0813 Boehringer Ingelheim Investigational Site Pragha 9
Czechia 1160.26.0811 Boehringer Ingelheim Investigational Site Prague 5
Czechia 1160.26.0812 Boehringer Ingelheim Investigational Site Praha 6
Czechia 1160.26.0817 Boehringer Ingelheim Investigational Site Pribram
Czechia 1160.26.0819 Boehringer Ingelheim Investigational Site Usti nad Orlici
Denmark 1160.26.0837 Boehringer Ingelheim Investigational Site Aalborg
Denmark 1160.26.0835 Boehringer Ingelheim Investigational Site Aarhus C
Denmark 1160.26.0838 Boehringer Ingelheim Investigational Site Frederikssund
Denmark 1160.26.0833 Boehringer Ingelheim Investigational Site Helsingør
Denmark 1160.26.0834 Boehringer Ingelheim Investigational Site Herlev
Denmark 1160.26.0841 Boehringer Ingelheim Investigational Site Horsens
Denmark 1160.26.0832 Boehringer Ingelheim Investigational Site Hvidovre
Denmark 1160.26.0840 Boehringer Ingelheim Investigational Site Køge
Denmark 1160.26.0831 Boehringer Ingelheim Investigational Site Odense
Denmark 1160.26.0839 Boehringer Ingelheim Investigational Site Roskilde
Denmark 1160.26.0836 Boehringer Ingelheim Investigational Site Svendborg
Finland 1160.26.0856 Boehringer Ingelheim Investigational Site Espoo
Finland 1160.26.0851 Boehringer Ingelheim Investigational Site HUS
Finland 1160.26.0859 Boehringer Ingelheim Investigational Site Jyväskylä
Finland 1160.26.0855 Boehringer Ingelheim Investigational Site Kuopio
Finland 1160.26.0857 Boehringer Ingelheim Investigational Site Lappeenranta
Finland 1160.26.0854 Boehringer Ingelheim Investigational Site OYS
Finland 1160.26.0858 Boehringer Ingelheim Investigational Site Pori
Finland 1160.26.0852 Boehringer Ingelheim Investigational Site Tampere
Finland 1160.26.0853 Boehringer Ingelheim Investigational Site Turku
France 1160.26.0875A Boehringer Ingelheim Investigational Site ABBEVILLE cedex
France 1160.26.0882A Boehringer Ingelheim Investigational Site Angers
France 1160.26.0882B Boehringer Ingelheim Investigational Site Angers
France 1160.26.0882C Boehringer Ingelheim Investigational Site Angers
France 1160.26.0882D Boehringer Ingelheim Investigational Site Angers
France 1160.26.0882E Boehringer Ingelheim Investigational Site Angers
France 1160.26.0882G Boehringer Ingelheim Investigational Site Angers
France 1160.26.0882H Boehringer Ingelheim Investigational Site Angers
France 1160.26.0882I Boehringer Ingelheim Investigational Site Angers
France 1160.26.0882K Boehringer Ingelheim Investigational Site Angers
France 1160.26.0882L Boehringer Ingelheim Investigational Site Angers
France 1160.26.0884A Boehringer Ingelheim Investigational Site Angers
France 1160.26.0887A Boehringer Ingelheim Investigational Site Cholet
France 1160.26.0889A Boehringer Ingelheim Investigational Site Gap
France 1160.26.0888A Boehringer Ingelheim Investigational Site Grenoble
France 1160.26.0879A Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0879B Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0879C Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0879E Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0879F Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0879G Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0879H Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0879S Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0880A Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0880F Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0880G Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0880J Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0881A Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0881D Boehringer Ingelheim Investigational Site Joue les Tours
France 1160.26.0880B Boehringer Ingelheim Investigational Site Joué les Tours
France 1160.26.0880C Boehringer Ingelheim Investigational Site Joué les Tours
France 1160.26.0880D Boehringer Ingelheim Investigational Site Joué les Tours
France 1160.26.0880E Boehringer Ingelheim Investigational Site Joué les Tours
France 1160.26.0874A Boehringer Ingelheim Investigational Site Langres
France 1160.26.0874B Boehringer Ingelheim Investigational Site Langres
France 1160.26.0871A Boehringer Ingelheim Investigational Site Paris
France 1160.26.0873A Boehringer Ingelheim Investigational Site TOULOUSE cedex
France 1160.26.0886A Boehringer Ingelheim Investigational Site Tourcoing
France 1160.26.0872B Boehringer Ingelheim Investigational Site Valenciennes
France 1160.26.0872A Boehringer Ingelheim Investigational Site VALENCIENNES cedex
France 1160.26.0872C Boehringer Ingelheim Investigational Site Valenciennes cedex
Germany 1160.26.0932 Boehringer Ingelheim Investigational Site Berlin
Germany 1160.26.0948 Boehringer Ingelheim Investigational Site Berlin
Germany 1160.26.0962 Boehringer Ingelheim Investigational Site Berlin
Germany 1160.26.0940 Boehringer Ingelheim Investigational Site Bochum
Germany 1160.26.0936 Boehringer Ingelheim Investigational Site Coburg
Germany 1160.26.0968 Boehringer Ingelheim Investigational Site Dachau
Germany 1160.26.0972 Boehringer Ingelheim Investigational Site Dortmund
Germany 1160.26.0957 Boehringer Ingelheim Investigational Site Duisburg
Germany 1160.26.0971 Boehringer Ingelheim Investigational Site Erlangen
Germany 1160.26.0965 Boehringer Ingelheim Investigational Site Eschweiler
Germany 1160.26.0934 Boehringer Ingelheim Investigational Site Essen
Germany 1160.26.0931 Boehringer Ingelheim Investigational Site Frankfurt/Main
Germany 1160.26.0943 Boehringer Ingelheim Investigational Site Heidelberg
Germany 1160.26.0955 Boehringer Ingelheim Investigational Site Kassel
Germany 1160.26.0963 Boehringer Ingelheim Investigational Site Köln
Germany 1160.26.0946 Boehringer Ingelheim Investigational Site Lahr
Germany 1160.26.0944 Boehringer Ingelheim Investigational Site Limburg
Germany 1160.26.0951 Boehringer Ingelheim Investigational Site Mainz
Germany 1160.26.0933 Boehringer Ingelheim Investigational Site Mannheim
Germany 1160.26.0945 Boehringer Ingelheim Investigational Site Mannheim
Germany 1160.26.0970 Boehringer Ingelheim Investigational Site Mannheim
Germany 1160.26.0947 Boehringer Ingelheim Investigational Site München
Germany 1160.26.0952 Boehringer Ingelheim Investigational Site München
Germany 1160.26.0941 Boehringer Ingelheim Investigational Site Papenburg
Germany 1160.26.0959 Boehringer Ingelheim Investigational Site Suhl
Germany 1160.26.0937 Boehringer Ingelheim Investigational Site Witten
Germany 1160.26.0966 Boehringer Ingelheim Investigational Site Wuppertal
Greece 1160.26.0908 University Hospital of Alexandroupolis Alexandroupolis
Greece 1160.26.0901 General Hospital "Alexandra", Therapeutic Clinic UOA Athens
Greece 1160.26.0906 General Hospital ";Evangelismos" Athens
Greece 1160.26.0907 "Pammakaristos" Hospital of Athens Athens
Greece 1160.26.0915 "Hippokratio" Hospital of Athens Athens
Greece 1160.26.0914 2nd IKA Hospital, Thessaloniki Kalamaria-Thessaloniki
Greece 1160.26.0904 General Hospital of Larissa Larissa
Greece 1160.26.0913 University Hospital of Larissa Larissa
Greece 1160.26.0912 General Hospital of Leivadia Leivadia
Greece 1160.26.0902 General Hospital " Papageorgiou" Thessaloniki
Greece 1160.26.0910 General Hospital of Thiva Thiva
Greece 1160.26.0903 General Hospital of Trikala Trikala
Greece 1160.26.0905 Boehringer Ingelheim Investigational Site Voula - Athens
Hong Kong 1160.26.1001 Boehringer Ingelheim Investigational Site Hong Kong
Hong Kong 1160.26.1002 Boehringer Ingelheim Investigational Site Hong Kong
Hong Kong 1160.26.1003 Boehringer Ingelheim Investigational Site Kowloon
Hong Kong 1160.26.1004 Boehringer Ingelheim Investigational Site Kowloon
Hungary 1160.26.1011 Boehringer Ingelheim Investigational Site Budapest
Hungary 1160.26.1012 Boehringer Ingelheim Investigational Site Budapest
Hungary 1160.26.1013 Boehringer Ingelheim Investigational Site Budapest
Hungary 1160.26.1014 Boehringer Ingelheim Investigational Site Budapest
Hungary 1160.26.1015 Boehringer Ingelheim Investigational Site Budapest
Hungary 1160.26.1016 Boehringer Ingelheim Investigational Site Budapest
Hungary 1160.26.1020 Boehringer Ingelheim Investigational Site Gyongyos
Hungary 1160.26.1017 Boehringer Ingelheim Investigational Site Komarom
Hungary 1160.26.1018 Boehringer Ingelheim Investigational Site Pecs
Hungary 1160.26.1019 Boehringer Ingelheim Investigational Site Veszprem
India 1160.26.1056 Boehringer Ingelheim Investigational Site Ahmedabad
India 1160.26.1057 Boehringer Ingelheim Investigational Site Ahmedabad
India 1160.26.1064 Boehringer Ingelheim Investigational Site Bangalore
India 1160.26.1065 Boehringer Ingelheim Investigational Site Bangalore
India 1160.26.1071 Boehringer Ingelheim Investigational Site Bikaner
India 1160.26.1066 Boehringer Ingelheim Investigational Site Chennai
India 1160.26.1069 Boehringer Ingelheim Investigational Site Coimbatore
India 1160.26.1062 Boehringer Ingelheim Investigational Site Hyderabad
India 1160.26.1058 Boehringer Ingelheim Investigational Site Indore
India 1160.26.1053 Boehringer Ingelheim Investigational Site Jaipur
India 1160.26.1073 Boehringer Ingelheim Investigational Site Jaipur
India 1160.26.1067 Boehringer Ingelheim Investigational Site Kerala
India 1160.26.1068 Boehringer Ingelheim Investigational Site Kottayam
India 1160.26.1055 Boehringer Ingelheim Investigational Site Lucknow
India 1160.26.1051 Boehringer Ingelheim Investigational Site Ludhiana
India 1160.26.1060 Boehringer Ingelheim Investigational Site Mumbai
India 1160.26.1072 Boehringer Ingelheim Investigational Site Mysore
India 1160.26.1059 Boehringer Ingelheim Investigational Site Nagpur
India 1160.26.1052 Boehringer Ingelheim Investigational Site New Delhi
India 1160.26.1070 Boehringer Ingelheim Investigational Site Pune
Israel 1160.26.1110 Boehringer Ingelheim Investigational Site Afula
Israel 1160.26.1121 Boehringer Ingelheim Investigational Site Afula
Israel 1160.26.1111 Boehringer Ingelheim Investigational Site Ashkelon
Israel 1160.26.1102 Boehringer Ingelheim Investigational Site Be´er Scheva
Israel 1160.26.1117 Boehringer Ingelheim Investigational Site Givatayim
Israel 1160.26.1112 Boehringer Ingelheim Investigational Site Hadera
Israel 1160.26.1091 Boehringer Ingelheim Investigational Site Haifa
Israel 1160.26.1113 Boehringer Ingelheim Investigational Site Haifa
Israel 1160.26.1114 Boehringer Ingelheim Investigational Site Haifa
Israel 1160.26.1116 Boehringer Ingelheim Investigational Site Haifa
Israel 1160.26.1118 Boehringer Ingelheim Investigational Site Haifa
Israel 1160.26.1105 Boehringer Ingelheim Investigational Site Holon
Israel 1160.26.1097 Boehringer Ingelheim Investigational Site Jerusalem
Israel 1160.26.1101 Boehringer Ingelheim Investigational Site Jerusalem
Israel 1160.26.1104 Boehringer Ingelheim Investigational Site Jerusalem
Israel 1160.26.1106 Boehringer Ingelheim Investigational Site Jerusalem
Israel 1160.26.1119 Boehringer Ingelheim Investigational Site Kfar Saba
Israel 1160.26.1115 Boehringer Ingelheim Investigational Site Nazareth
Israel 1160.26.1096 Boehringer Ingelheim Investigational Site Petah Tikva
Israel 1160.26.1093 Boehringer Ingelheim Investigational Site Ramat Gan
Israel 1160.26.1094 Boehringer Ingelheim Investigational Site Ramat Gan
Israel 1160.26.1095 Boehringer Ingelheim Investigational Site Ramat Gan
Israel 1160.26.1100 Boehringer Ingelheim Investigational Site Rehovot
Israel 1160.26.1103 Boehringer Ingelheim Investigational Site Safed
Israel 1160.26.1092 Boehringer Ingelheim Investigational Site Tel Hashomer
Israel 1160.26.1098 Boehringer Ingelheim Investigational Site Tel Hashomer
Israel 1160.26.1107 Boehringer Ingelheim Investigational Site Tel-Aviv
Israel 1160.26.1108 Boehringer Ingelheim Investigational Site Tel-Aviv
Israel 1160.26.1109 Boehringer Ingelheim Investigational Site Tel-Aviv
Israel 1160.26.1120 Boehringer Ingelheim Investigational Site Tel-Aviv
Israel 1160.26.1122 Boehringer Ingelheim Investigational Site Tel-Aviv
Israel 1160.26.1099 Boehringer Ingelheim Investigational Site Zerifin
Italy 1160.26.1169 Boehringer Ingelheim Investigational Site Arezzo
Italy 1160.26.1172 Boehringer Ingelheim Investigational Site Ascoli Piceno
Italy 1160.26.1180 Boehringer Ingelheim Investigational Site Bentivoglio (BO)
Italy 1160.26.1161 Boehringer Ingelheim Investigational Site Bologna
Italy 1160.26.1163 Boehringer Ingelheim Investigational Site Castelnuovo Garfagnana
Italy 1160.26.1178 Boehringer Ingelheim Investigational Site Chieti
Italy 1160.26.1171 Boehringer Ingelheim Investigational Site Colleferro
Italy 1160.26.1174 Boehringer Ingelheim Investigational Site Cremona
Italy 1160.26.1167 Boehringer Ingelheim Investigational Site Eboli
Italy 1160.26.1168 Boehringer Ingelheim Investigational Site Isernia
Italy 1160.26.1162 Boehringer Ingelheim Investigational Site Legnago
Italy 1160.26.1177 Boehringer Ingelheim Investigational Site Mantova
Italy 1160.26.1165 Boehringer Ingelheim Investigational Site Perugia SAN Sisto
Italy 1160.26.1175 Boehringer Ingelheim Investigational Site Roma
Italy 1160.26.1181 Boehringer Ingelheim Investigational Site San Bonifacio
Italy 1160.26.1173 Boehringer Ingelheim Investigational Site San Daniele Del Friuli
Italy 1160.26.1170 Boehringer Ingelheim Investigational Site Sassari
Italy 1160.26.1176 Boehringer Ingelheim Investigational Site Sassari
Japan 1160.26.1204 Boehringer Ingelheim Investigational Site Abeno-ku, Osaka, Osaka
Japan 1160.26.1209 Boehringer Ingelheim Investigational Site Aki-gun, Hiroshima
Japan 1160.26.1193 Boehringer Ingelheim Investigational Site Aoba-ku, Sendai, Miyagi
Japan 1160.26.1211 Boehringer Ingelheim Investigational Site Chuo-ku, Fukuoka, Fukuoka
Japan 1160.26.1225 Boehringer Ingelheim Investigational Site Chuo-ku, Fukuoka, Fukuoka
Japan 1160.26.1221 Boehringer Ingelheim Investigational Site Chuo-ku, Kobe, Hyogo
Japan 1160.26.1219 Boehringer Ingelheim Investigational Site Chuo-ku, Osaka, Osaka
Japan 1160.26.1229 Boehringer Ingelheim Investigational Site Fujioka-shi , Gunma-ken
Japan 1160.26.1232 Boehringer Ingelheim Investigational Site Fukushima-shi,Fukushima-ken
Japan 1160.26.1228 Boehringer Ingelheim Investigational Site Higashimatsushimashi, Miyagi-ken
Japan 1160.26.1208 Boehringer Ingelheim Investigational Site Himeji, Hyogo
Japan 1160.26.1214 Boehringer Ingelheim Investigational Site Iida, Nagano
Japan 1160.26.1240 Boehringer Ingelheim Investigational Site Isesaki-shi,Gunma
Japan 1160.26.1224 Boehringer Ingelheim Investigational Site Iwakuni, Yamaguchi
Japan 1160.26.1194 Boehringer Ingelheim Investigational Site Izumi-ku, Sendai, Miyagi
Japan 1160.26.1241 Boehringer Ingelheim Investigational Site Kamigyo-ku, Kyoto
Japan 1160.26.1220 Boehringer Ingelheim Investigational Site Kawachinagano, Osaka
Japan 1160.26.1203 Boehringer Ingelheim Investigational Site Kita-ku, Osaka, Osaka
Japan 1160.26.1207 Boehringer Ingelheim Investigational Site Kita-ku, Sakai, Osaka
Japan 1160.26.1231 Boehringer Ingelheim Investigational Site Komatsu-shi,Ishikawa -ken
Japan 1160.26.1233 Boehringer Ingelheim Investigational Site Kyoto-shi,Kyoto
Japan 1160.26.1242 Boehringer Ingelheim Investigational Site Matsumoto, Nagano
Japan 1160.26.1210 Boehringer Ingelheim Investigational Site Minami-ku, Fukuoka, Fukuoka
Japan 1160.26.1218 Boehringer Ingelheim Investigational Site Minato, Tokyo
Japan 1160.26.1200 Boehringer Ingelheim Investigational Site Minato-ku, Nagoya, Aichi
Japan 1160.26.1201 Boehringer Ingelheim Investigational Site Minato-ku, Nagoya, Aichi
Japan 1160.26.1216 Boehringer Ingelheim Investigational Site Narashino, Chiba
Japan 1160.26.1237 Boehringer Ingelheim Investigational Site Nishinomiya-shi,Hyogo
Japan 1160.26.1223 Boehringer Ingelheim Investigational Site Okayama, Okayama
Japan 1160.26.1197 Boehringer Ingelheim Investigational Site Oota, Tokyo
Japan 1160.26.1212 Boehringer Ingelheim Investigational Site Otaru, Hokkaido
Japan 1160.26.1230 Boehringer Ingelheim Investigational Site Sagamihara, Kanagawa-ken
Japan 1160.26.1238 Boehringer Ingelheim Investigational Site Sapporo-shi,Hokkai-do
Japan 1160.26.1217 Boehringer Ingelheim Investigational Site Shibuya, Tokyo
Japan 1160.26.1196 Boehringer Ingelheim Investigational Site Shinjuku, Tokyo
Japan 1160.26.1191 Boehringer Ingelheim Investigational Site Shiroishi-ku, Sapporo, Hokkaido
Japan 1160.26.1192 Boehringer Ingelheim Investigational Site Shiroishi-ku, Sapporo, Hokkaido
Japan 1160.26.1206 Boehringer Ingelheim Investigational Site Suita, Osaka
Japan 1160.26.1235 Boehringer Ingelheim Investigational Site Suita-shi, Osaka
Japan 1160.26.1236 Boehringer Ingelheim Investigational Site Suita-shi, Osaka
Japan 1160.26.1205 Boehringer Ingelheim Investigational Site Sumiyoshi-ku, Osaka, Osaka
Japan 1160.26.1234 Boehringer Ingelheim Investigational Site Takatsuki-shi,Osaka
Japan 1160.26.1215 Boehringer Ingelheim Investigational Site Tokorozawa, Saitama
Japan 1160.26.1198 Boehringer Ingelheim Investigational Site Totsuka-ku, Yokohama, Kanagawa
Japan 1160.26.1195 Boehringer Ingelheim Investigational Site Tsuchiura, Ibaragi
Japan 1160.26.1199 Boehringer Ingelheim Investigational Site Ueda, Nagano
Japan 1160.26.1222 Boehringer Ingelheim Investigational Site Wakayama, Wakayama
Japan 1160.26.1227 Boehringer Ingelheim Investigational Site Yanagawa, Fukuoka
Japan 1160.26.1243 Boehringer Ingelheim Investigational Site Yao, Osaka
Korea, Republic of 1160.26.1585 Boehringer Ingelheim Investigational Site Busan
Korea, Republic of 1160.26.1586 Boehringer Ingelheim Investigational Site Chungchungnam-Do
Korea, Republic of 1160.26.1584 Boehringer Ingelheim Investigational Site Daegu
Korea, Republic of 1160.26.1591 Boehringer Ingelheim Investigational Site Daegu
Korea, Republic of 1160.26.1590 Boehringer Ingelheim Investigational Site Gwangju
Korea, Republic of 1160.26.1581 Boehringer Ingelheim Investigational Site Incheon
Korea, Republic of 1160.26.1582 Boehringer Ingelheim Investigational Site Seoul
Korea, Republic of 1160.26.1583 Boehringer Ingelheim Investigational Site Seoul
Korea, Republic of 1160.26.1588 Boehringer Ingelheim Investigational Site Seoul
Korea, Republic of 1160.26.1589 Boehringer Ingelheim Investigational Site Seoul
Korea, Republic of 1160.26.1592 Boehringer Ingelheim Investigational Site Seoul
Korea, Republic of 1160.26.1593 Boehringer Ingelheim Investigational Site Seoul
Malaysia 1160.26.1297 Boehringer Ingelheim Investigational Site Kajang,Selangor
Malaysia 1160.26.1291 Boehringer Ingelheim Investigational Site Kuala Lumpur
Malaysia 1160.26.1292 Boehringer Ingelheim Investigational Site Kuala Lumpur
Malaysia 1160.26.1294 Boehringer Ingelheim Investigational Site Kuala Lumpur
Malaysia 1160.26.1293 Boehringer Ingelheim Investigational Site Kuching
Malaysia 1160.26.1295 Boehringer Ingelheim Investigational Site Penang
Malaysia 1160.26.1296 Boehringer Ingelheim Investigational Site Penang
Mexico 1160.26.1318 Hospital General "Dr. Santiago Ramón y Cajal Durango
Mexico 1160.26.1311 Hospital Mexico-Americano Guadalajara
Mexico 1160.26.1317 hOSPITAL bERNARDETTE Guadalajara
Mexico 1160.26.1312 Hospital de Jesus Mexico
Mexico 1160.26.1319 Instituto Nacional de Cardiologia Mexico
Mexico 1160.26.1314 Hospital 1o. de Octubre México
Mexico 1160.26.1313 Hosp. Angeles Centro Medico del Potosi San Luis Potosí
Mexico 1160.26.1322 Hospital Central "Dr. Ignacio Morones Prieto" San Luis Potosí
Netherlands 1160.26.1344 Boehringer Ingelheim Investigational Site Almelo
Netherlands 1160.26.1331 Boehringer Ingelheim Investigational Site Amsterdam
Netherlands 1160.26.1336 Boehringer Ingelheim Investigational Site Apeldoorn
Netherlands 1160.26.1332 Boehringer Ingelheim Investigational Site Breda
Netherlands 1160.26.1337 Boehringer Ingelheim Investigational Site Den Bosch
Netherlands 1160.26.1349 Boehringer Ingelheim Investigational Site Den Helder
Netherlands 1160.26.1345 Boehringer Ingelheim Investigational Site Deventer
Netherlands 1160.26.1360 Boehringer Ingelheim Investigational Site Dirksland
Netherlands 1160.26.1348 Boehringer Ingelheim Investigational Site Dordrecht
Netherlands 1160.26.1340 Boehringer Ingelheim Investigational Site Ede
Netherlands 1160.26.1358 Boehringer Ingelheim Investigational Site Eindhoven
Netherlands 1160.26.1338 Boehringer Ingelheim Investigational Site Enschede
Netherlands 1160.26.1343 Boehringer Ingelheim Investigational Site Goes
Netherlands 1160.26.1347 Boehringer Ingelheim Investigational Site Gorinchem
Netherlands 1160.26.1333 Boehringer Ingelheim Investigational Site Groningen
Netherlands 1160.26.1355 Boehringer Ingelheim Investigational Site Groningen
Netherlands 1160.26.1361 Boehringer Ingelheim Investigational Site Heerlen
Netherlands 1160.26.1339 Boehringer Ingelheim Investigational Site Hengelo
Netherlands 1160.26.1346 Boehringer Ingelheim Investigational Site Hilversum
Netherlands 1160.26.1356 Boehringer Ingelheim Investigational Site Hoorn
Netherlands 1160.26.1359 Boehringer Ingelheim Investigational Site Maastricht
Netherlands 1160.26.1341 Boehringer Ingelheim Investigational Site Meppel
Netherlands 1160.26.1354 Boehringer Ingelheim Investigational Site Rotterdam
Netherlands 1160.26.1351 Boehringer Ingelheim Investigational Site Sneek
Netherlands 1160.26.1334 Boehringer Ingelheim Investigational Site Spiijkenisse
Netherlands 1160.26.1335 Boehringer Ingelheim Investigational Site Terneuzen
Netherlands 1160.26.1353 Boehringer Ingelheim Investigational Site Tiel
Netherlands 1160.26.1352 Boehringer Ingelheim Investigational Site Tilburg
Netherlands 1160.26.1350 Boehringer Ingelheim Investigational Site Veldhoven
Netherlands 1160.26.1342 Boehringer Ingelheim Investigational Site Velp
Netherlands 1160.26.1357 Boehringer Ingelheim Investigational Site Venlo
Norway 1160.26.1396 Boehringer Ingelheim Investigational Site Gjøvik
Norway 1160.26.1393 Boehringer Ingelheim Investigational Site Moss
Norway 1160.26.1395 Boehringer Ingelheim Investigational Site Nordbyhagen
Norway 1160.26.1391 Boehringer Ingelheim Investigational Site Oslo
Norway 1160.26.1392 Boehringer Ingelheim Investigational Site Oslo
Norway 1160.26.1397 Boehringer Ingelheim Investigational Site Oslo
Norway 1160.26.1394 Boehringer Ingelheim Investigational Site RUD
Peru 1160.26.1415 Hospital Alberto Sabogal Bella Vista
Peru 1160.26.1411 Clinica San Felipe Jesús María
Peru 1160.26.1412 Clínica Anglo Americana San Isidro
Peru 1160.26.1413 Hospital Cayetano Heredia San Martín de Porres
Peru 1160.26.1414 Clínica Vesalio Urbanización Sto Tomas De San Borja
Philippines 1160.26.1421 Philippine General Hospital Manila
Philippines 1160.26.1422 Manila Doctors Hospital Manila
Philippines 1160.26.1424 The Medical City Pasig City
Philippines 1160.26.1423 Philippine Heart Center Quezon City
Philippines 1160.26.1425 St Lukes Medical Center Quezon City
Poland 1160.26.1436 Boehringer Ingelheim Investigational Site Gdynia
Poland 1160.26.1438 Boehringer Ingelheim Investigational Site Gdynia
Poland 1160.26.1437 Boehringer Ingelheim Investigational Site Gdynia Redlowo
Poland 1160.26.1435 Boehringer Ingelheim Investigational Site Katowice
Poland 1160.26.1439 Boehringer Ingelheim Investigational Site Krakow
Poland 1160.26.1440 Boehringer Ingelheim Investigational Site Krakow
Poland 1160.26.1433 Boehringer Ingelheim Investigational Site Pulawy
Poland 1160.26.1431 Boehringer Ingelheim Investigational Site Warsaw
Poland 1160.26.1432 Boehringer Ingelheim Investigational Site Warsaw
Poland 1160.26.1434 Boehringer Ingelheim Investigational Site Zabrze
Portugal 1160.26.1456 Boehringer Ingelheim Investigational Site Amadora
Portugal 1160.26.1451 Boehringer Ingelheim Investigational Site Carnaxide
Portugal 1160.26.1454 Boehringer Ingelheim Investigational Site Coimbra
Portugal 1160.26.1459 Boehringer Ingelheim Investigational Site Coimbra
Portugal 1160.26.1457 Boehringer Ingelheim Investigational Site Covilhã
Portugal 1160.26.1453 Boehringer Ingelheim Investigational Site Lisboa
Portugal 1160.26.1458 Boehringer Ingelheim Investigational Site Lisboa
Portugal 1160.26.1455 Boehringer Ingelheim Investigational Site Porto
Portugal 1160.26.1452 Boehringer Ingelheim Investigational Site Setúbal
Romania 1160.26.1471 Boehringer Ingelheim Investigational Site Bucharest
Romania 1160.26.1472 Boehringer Ingelheim Investigational Site Bucharest
Romania 1160.26.1478 Boehringer Ingelheim Investigational Site Cluj Napoca
Russian Federation 1160.26.1501 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1502 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1503 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1504 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1505 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1506 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1507 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1508 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1509 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1510 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1511 Boehringer Ingelheim Investigational Site Moscow
Russian Federation 1160.26.1512 Boehringer Ingelheim Investigational Site St. Petersburg
Russian Federation 1160.26.1513 Boehringer Ingelheim Investigational Site St. Petersburg
Russian Federation 1160.26.1514 Boehringer Ingelheim Investigational Site St. Petersburg
Russian Federation 1160.26.1515 Boehringer Ingelheim Investigational Site St. Petersburg
Singapore 1160.26.1531 Boehringer Ingelheim Investigational Site Singapore
Singapore 1160.26.1532 Boehringer Ingelheim Investigational Site Singapore
Slovakia 1160.26.1548 Boehringer Ingelheim Investigational Site Banska Bystrica
Slovakia 1160.26.1541 Boehringer Ingelheim Investigational Site Bratislava
Slovakia 1160.26.1542 Boehringer Ingelheim Investigational Site Bratislava
Slovakia 1160.26.1543 Boehringer Ingelheim Investigational Site Bratislava
Slovakia 1160.26.1544 Boehringer Ingelheim Investigational Site Bratislava
Slovakia 1160.26.1545 Boehringer Ingelheim Investigational Site Bratislava
Slovakia 1160.26.1546 Boehringer Ingelheim Investigational Site Bratislava
Slovakia 1160.26.1549 Boehringer Ingelheim Investigational Site Kosice
Slovakia 1160.26.1550 Boehringer Ingelheim Investigational Site Kosice
Slovakia 1160.26.1547 Boehringer Ingelheim Investigational Site Zilina
South Africa 1160.26.1562 Boehringer Ingelheim Investigational Site Bloemfontein
South Africa 1160.26.1569 Boehringer Ingelheim Investigational Site Boksburg
South Africa 1160.26.1561 Boehringer Ingelheim Investigational Site Cape Town
South Africa 1160.26.1564 Boehringer Ingelheim Investigational Site Johannesburg
South Africa 1160.26.1567 Boehringer Ingelheim Investigational Site Johannesburg
South Africa 1160.26.1568 Boehringer Ingelheim Investigational Site Johannesburg
South Africa 1160.26.1566 Boehringer Ingelheim Investigational Site Pretoria
South Africa 1160.26.1563 Boehringer Ingelheim Investigational Site Randburg
South Africa 1160.26.1565 Boehringer Ingelheim Investigational Site Somerset West
Spain 1160.26.1601 Boehringer Ingelheim Investigational Site Barcelona
Spain 1160.26.1606 Boehringer Ingelheim Investigational Site Cadiz
Spain 1160.26.1607 Boehringer Ingelheim Investigational Site Fuenlabrada (Madrid)
Spain 1160.26.1604 Boehringer Ingelheim Investigational Site Leganés, Madrid
Spain 1160.26.1603 Boehringer Ingelheim Investigational Site Madrid
Spain 1160.26.1608 Boehringer Ingelheim Investigational Site Madrid
Spain 1160.26.1609 Boehringer Ingelheim Investigational Site Madrid-San Lorenzo Del Escorial
Spain 1160.26.1605 Boehringer Ingelheim Investigational Site Móstoles (Madrid)
Spain 1160.26.1602 Boehringer Ingelheim Investigational Site Sabadell
Sweden 1160.26.1633 Sahlgrenska Sjukhuset Göteboerg
Sweden 1160.26.1629 AVK-mott, Spec.M1, Länssjukhuset Ryhov Jönköping
Sweden 1160.26.1631 Universitetssjukhuset i Linköping Linköping
Sweden 1160.26.1627 Hjärtmott. ING 35, Malmö Universitetssjukhus MAS Malmö
Sweden 1160.26.1628 Rådhusg. 29, Lars Mörlids Läkarmottagning Nässjö
Sweden 1160.26.1625 Hjärtmott./Medicinkliniken, Vrinnevisjukhuset Norrköping
Sweden 1160.26.1623 Kardiologiska kliniken, Universitetssjukhuset Örebro
Sweden 1160.26.1626 Hjärtkärllaboratoriet, Danderyds Sjukhus AB Stockholm
Sweden 1160.26.1632 Capio S:t Görans Sjukhus Stockholm
Sweden 1160.26.1634 Södersjukhuset Stockholm
Sweden 1160.26.1624 Klin. forskningscentrum, Norrlands Universitetssjukhus Umeå
Sweden 1160.26.1621 Kardiologiska kliniken, Akademiska Sjukhuset Uppsala
Sweden 1160.26.1635 UCR/Uppsala Uppsala
Sweden 1160.26.1622 Hjärtmottagningen, Centrallasarettet Västerås
Switzerland 1160.26.1652 Boehringer Ingelheim Investigational Site Basel
Switzerland 1160.26.1655 Boehringer Ingelheim Investigational Site Bellinzona
Switzerland 1160.26.1651 Boehringer Ingelheim Investigational Site Bern
Switzerland 1160.26.1654 Boehringer Ingelheim Investigational Site Lugano
Taiwan 1160.26.1680 Boehringer Ingelheim Investigational Site Changhua County
Taiwan 1160.26.1683 Boehringer Ingelheim Investigational Site Hualien
Taiwan 1160.26.1682 Boehringer Ingelheim Investigational Site Kaohsiung
Taiwan 1160.26.1679 China Medical University Hospital Taichung
Taiwan 1160.26.1681 Boehringer Ingelheim Investigational Site Tainan
Taiwan 1160.26.1671 Boehringer Ingelheim Investigational Site Taipei
Taiwan 1160.26.1672 Boehringer Ingelheim Investigational Site Taipei
Taiwan 1160.26.1673 Boehringer Ingelheim Investigational Site Taipei
Taiwan 1160.26.1674 Boehringer Ingelheim Investigational Site Taipei
Taiwan 1160.26.1675 Boehringer Ingelheim Investigational Site Taipei
Taiwan 1160.26.1676 Boehringer Ingelheim Investigational Site Taipei
Taiwan 1160.26.1677 Boehringer Ingelheim Investigational Site Taipei
Taiwan 1160.26.1678 Boehringer Ingelheim Investigational Site Taoyuan
Thailand 1160.26.1701 Boehringer Ingelheim Investigational Site Bangkok
Thailand 1160.26.1702 Boehringer Ingelheim Investigational Site Bangkok
Thailand 1160.26.1703 Boehringer Ingelheim Investigational Site Chiangmai
Thailand 1160.26.1704 Boehringer Ingelheim Investigational Site Khon Kaen
Thailand 1160.26.1705 Boehringer Ingelheim Investigational Site Muang Nakhonratchasima
Turkey 1160.26.1715 Boehringer Ingelheim Investigational Site Adana
Turkey 1160.26.1711 Boehringer Ingelheim Investigational Site Ankara
Turkey 1160.26.1713 Gazi Universitesi Tip Fakultesi Kardiyoloji Abd Ankara
Turkey 1160.26.1714 Dokuz Eylul Universitesi Tip Fakultesi Izmir
Ukraine 1160.26.1727 Boehringer Ingelheim Investigational Site Dnyepropetrovsk
Ukraine 1160.26.1726 Boehringer Ingelheim Investigational Site Kharkiv
Ukraine 1160.26.1724 Boehringer Ingelheim Investigational Site Kharkov
Ukraine 1160.26.1725 Boehringer Ingelheim Investigational Site Kharkov
Ukraine 1160.26.1721 Boehringer Ingelheim Investigational Site Kiev
Ukraine 1160.26.1722 Boehringer Ingelheim Investigational Site Kiev
Ukraine 1160.26.1723 Boehringer Ingelheim Investigational Site Kiev
Ukraine 1160.26.1728 Boehringer Ingelheim Investigational Site Kiev
Ukraine 1160.26.1730 Boehringer Ingelheim Investigational Site Kiev
Ukraine 1160.26.1731 Boehringer Ingelheim Investigational Site Kiev
Ukraine 1160.26.1729 Boehringer Ingelheim Investigational Site Lvov
United Kingdom 1160.26.1744 Boehringer Ingelheim Investigational Site Birmingham
United Kingdom 1160.26.1746 Boehringer Ingelheim Investigational Site Chertsey
United Kingdom 1160.26.1747 Boehringer Ingelheim Investigational Site Glasgow
United Kingdom 1160.26.1750 Boehringer Ingelheim Investigational Site Harrow
United Kingdom 1160.26.1753 Boehringer Ingelheim Investigational Site Hull
United Kingdom 1160.26.1755 Boehringer Ingelheim Investigational Site Kirkcaldy, Fife
United Kingdom 1160.26.1741 Boehringer Ingelheim Investigational Site London
United Kingdom 1160.26.1756 Boehringer Ingelheim Investigational Site London
United Kingdom 1160.26.1749 Boehringer Ingelheim Investigational Site Londonderry
United Kingdom 1160.26.1742 Boehringer Ingelheim Investigational Site Newcastle upon Tyne
United Kingdom 1160.26.1751 Boehringer Ingelheim Investigational Site Newport
United Kingdom 1160.26.1752 Boehringer Ingelheim Investigational Site Northampton
United Kingdom 1160.26.1745 Boehringer Ingelheim Investigational Site Portadown, County Atrim
United Kingdom 1160.26.1743 Boehringer Ingelheim Investigational Site Romford, Essex
United Kingdom 1160.26.1754 Boehringer Ingelheim Investigational Site Stoke-On-Trent
United Kingdom 1160.26.1748 Boehringer Ingelheim Investigational Site York
United States 1160.26.0203 Boehringer Ingelheim Investigational Site Akron Ohio
United States 1160.26.0476 Boehringer Ingelheim Investigational Site Albany New York
United States 1160.26.0127 Boehringer Ingelheim Investigational Site Albuquerque New Mexico
United States 1160.26.0423 Boehringer Ingelheim Investigational Site Albuquerque New Mexico
United States 1160.26.0301 Boehringer Ingelheim Investigational Site Allentown Pennsylvania
United States 1160.26.0128 Boehringer Ingelheim Investigational Site Alliance Nebraska
United States 1160.26.0454 Boehringer Ingelheim Investigational Site Altoona Pennsylvania
United States 1160.26.0388 Boehringer Ingelheim Investigational Site Anaheim California
United States 1160.26.0114 Boehringer Ingelheim Investigational Site Annapolis Maryland
United States 1160.26.0164 Boehringer Ingelheim Investigational Site Annapolis Maryland
United States 1160.26.0195 Boehringer Ingelheim Investigational Site Arlington Virginia
United States 1160.26.0353 Boehringer Ingelheim Investigational Site Asheville North Carolina
United States 1160.26.0159 Boehringer Ingelheim Investigational Site Atlanta Georgia
United States 1160.26.0283 Boehringer Ingelheim Investigational Site Atlanta Georgia
United States 1160.26.0338 Boehringer Ingelheim Investigational Site Atlanta Georgia
United States 1160.26.0022 Boehringer Ingelheim Investigational Site Atlantis Florida
United States 1160.26.0096 Boehringer Ingelheim Investigational Site Auburn Maine
United States 1160.26.0021 Boehringer Ingelheim Investigational Site Augusta Georgia
United States 1160.26.0319 Boehringer Ingelheim Investigational Site Augusta Georgia
United States 1160.26.0419 Boehringer Ingelheim Investigational Site Aurora Colorado
United States 1160.26.0129 Boehringer Ingelheim Investigational Site Austin Texas
United States 1160.26.0410 Boehringer Ingelheim Investigational Site Austin Texas
United States 1160.26.0042 Boehringer Ingelheim Investigational Site Ayer Massachusetts
United States 1160.26.0023 Boehringer Ingelheim Investigational Site Baltimore Maryland
United States 1160.26.0047 Boehringer Ingelheim Investigational Site Baltimore Maryland
United States 1160.26.0079 Boehringer Ingelheim Investigational Site Baltimore Maryland
United States 1160.26.0186 Boehringer Ingelheim Investigational Site Baltimore Maryland
United States 1160.26.0194 Boehringer Ingelheim Investigational Site Baltimore Maryland
United States 1160.26.0155 Boehringer Ingelheim Investigational Site Bartlesville Oklahoma
United States 1160.26.0011 Boehringer Ingelheim Investigational Site Baton Rouge Louisiana
United States 1160.26.0144 Boehringer Ingelheim Investigational Site Baton Rouge Louisiana
United States 1160.26.0404 Boehringer Ingelheim Investigational Site Baton Rouge Louisiana
United States 1160.26.0007 Boehringer Ingelheim Investigational Site Beaufort South Carolina
United States 1160.26.0255 Boehringer Ingelheim Investigational Site Bel Air Maryland
United States 1160.26.0287 Boehringer Ingelheim Investigational Site Bellevue Washington
United States 1160.26.0050 Boehringer Ingelheim Investigational Site Bellingham Washington
United States 1160.26.0218 Boehringer Ingelheim Investigational Site Berwyn Illinois
United States 1160.26.0009 Boehringer Ingelheim Investigational Site Birmingham Alabama
United States 1160.26.0046 Boehringer Ingelheim Investigational Site Birmingham Alabama
United States 1160.26.0057 Boehringer Ingelheim Investigational Site Birmingham Alabama
United States 1160.26.0211 Boehringer Ingelheim Investigational Site Birmingham Alabama
United States 1160.26.0141 Boehringer Ingelheim Investigational Site Bloomfield Hills Michigan
United States 1160.26.0092 Boehringer Ingelheim Investigational Site Blue Ridge Georgia
United States 1160.26.0401 Boehringer Ingelheim Investigational Site Boston Massachusetts
United States 1160.26.0077 Boehringer Ingelheim Investigational Site Bowling Green Kentucky
United States 1160.26.0382 Boehringer Ingelheim Investigational Site Boynton Beach Florida
United States 1160.26.0056 Boehringer Ingelheim Investigational Site Brandon Florida
United States 1160.26.0058 Boehringer Ingelheim Investigational Site Bridgeport Connecticut
United States 1160.26.0241 Boehringer Ingelheim Investigational Site Bridgeport Connecticut
United States 1160.26.0278 Boehringer Ingelheim Investigational Site Bridgeport Connecticut
United States 1160.26.0113 Boehringer Ingelheim Investigational Site Bronx New York
United States 1160.26.0281 Boehringer Ingelheim Investigational Site Bronx New York
United States 1160.26.0142 Boehringer Ingelheim Investigational Site Browns Mills New Jersey
United States 1160.26.0063 Boehringer Ingelheim Investigational Site Buffalo New York
United States 1160.26.0040 Boehringer Ingelheim Investigational Site Burien Washington
United States 1160.26.0295 Boehringer Ingelheim Investigational Site Camp Hill Pennsylvania
United States 1160.26.0434 Boehringer Ingelheim Investigational Site Canal Fulton Ohio
United States 1160.26.0441 Boehringer Ingelheim Investigational Site Carmichael California
United States 1160.26.0193 Boehringer Ingelheim Investigational Site Charleston West Virginia
United States 1160.26.0383 Boehringer Ingelheim Investigational Site Charleston South Carolina
United States 1160.26.0080 Boehringer Ingelheim Investigational Site Charlotte North Carolina
United States 1160.26.0412 Boehringer Ingelheim Investigational Site Charlotte North Carolina
United States 1160.26.0453 Boehringer Ingelheim Investigational Site Charlottesville Virginia
United States 1160.26.0084 Boehringer Ingelheim Investigational Site Chattanooga Tennessee
United States 1160.26.0125 Boehringer Ingelheim Investigational Site Cherry Hill New Jersey
United States 1160.26.0053 Boehringer Ingelheim Investigational Site Chesapeake Virginia
United States 1160.26.0184 Boehringer Ingelheim Investigational Site Chicago Illinois
United States 1160.26.0233 Boehringer Ingelheim Investigational Site Chicago Illinois
United States 1160.26.0324 Boehringer Ingelheim Investigational Site Chicago Illinois
United States 1160.26.0457 Boehringer Ingelheim Investigational Site Chicago Illinois
United States 1160.26.0083 Boehringer Ingelheim Investigational Site Cincinnati Ohio
United States 1160.26.0402 Boehringer Ingelheim Investigational Site Cincinnati Ohio
United States 1160.26.0426 Boehringer Ingelheim Investigational Site Cincinnati Ohio
United States 1160.26.0479 Boehringer Ingelheim Investigational Site Cincinnati Ohio
United States 1160.26.0169 Boehringer Ingelheim Investigational Site Clarksburg West Virginia
United States 1160.26.0105 Boehringer Ingelheim Investigational Site Clearwater Florida
United States 1160.26.0296 Boehringer Ingelheim Investigational Site Clearwater Florida
United States 1160.26.0429 Boehringer Ingelheim Investigational Site Clearwater Florida
United States 1160.26.0263 Boehringer Ingelheim Investigational Site Cleveland Ohio
United States 1160.26.0480 Boehringer Ingelheim Investigational Site Cleveland Ohio
United States 1160.26.0026 Boehringer Ingelheim Investigational Site Coeur d'Alene Idaho
United States 1160.26.0321 Boehringer Ingelheim Investigational Site Colorado Springs Colorado
United States 1160.26.0449 Boehringer Ingelheim Investigational Site Colorado Springs Colorado
United States 1160.26.0055 Boehringer Ingelheim Investigational Site Columbia Missouri
United States 1160.26.0172 Boehringer Ingelheim Investigational Site Columbia Missouri
United States 1160.26.0398 Boehringer Ingelheim Investigational Site Columbia Maryland
United States 1160.26.0267 Boehringer Ingelheim Investigational Site Columbus Ohio
United States 1160.26.0161 Boehringer Ingelheim Investigational Site Conyers Georgia
United States 1160.26.0044 Boehringer Ingelheim Investigational Site Cortlandt Manor New York
United States 1160.26.0139 Boehringer Ingelheim Investigational Site Corvallis Oregon
United States 1160.26.0093 Boehringer Ingelheim Investigational Site Covington Louisiana
United States 1160.26.0138 Boehringer Ingelheim Investigational Site Crestview Hills Kentucky
United States 1160.26.0156 Boehringer Ingelheim Investigational Site Dallas Texas
United States 1160.26.0098 Boehringer Ingelheim Investigational Site Danville Virginia
United States 1160.26.0035 Boehringer Ingelheim Investigational Site Dayton Ohio
United States 1160.26.0376 Boehringer Ingelheim Investigational Site Daytona Beach Florida
United States 1160.26.0411 Boehringer Ingelheim Investigational Site Deerfield Beach Florida
United States 1160.26.0360 Boehringer Ingelheim Investigational Site Denver Colorado
United States 1160.26.0413 Boehringer Ingelheim Investigational Site Denver Colorado
United States 1160.26.0225 Boehringer Ingelheim Investigational Site Detroit Michigan
United States 1160.26.0268 Boehringer Ingelheim Investigational Site Dubuque Iowa
United States 1160.26.0160 Boehringer Ingelheim Investigational Site East Bridgewater Massachusetts
United States 1160.26.0072 Boehringer Ingelheim Investigational Site Elkhorn Wisconsin
United States 1160.26.0432 Boehringer Ingelheim Investigational Site Elmer New Jersey
United States 1160.26.0448 Boehringer Ingelheim Investigational Site Englewood New Jersey
United States 1160.26.0325 Boehringer Ingelheim Investigational Site Eugene Oregon
United States 1160.26.0237 Boehringer Ingelheim Investigational Site Evanston Illinois
United States 1160.26.0041 Boehringer Ingelheim Investigational Site Evansville Indiana
United States 1160.26.0085 Boehringer Ingelheim Investigational Site Fairfield Connecticut
United States 1160.26.0150 Boehringer Ingelheim Investigational Site Fairview Park Ohio
United States 1160.26.0386 Boehringer Ingelheim Investigational Site Falls Church Virginia
United States 1160.26.0248 Boehringer Ingelheim Investigational Site Flemington New Jersey
United States 1160.26.0373 Boehringer Ingelheim Investigational Site Flushing New York
United States 1160.26.0362 Boehringer Ingelheim Investigational Site Fort Collins Colorado
United States 1160.26.0074 Boehringer Ingelheim Investigational Site Fort Myers Florida
United States 1160.26.0377 Boehringer Ingelheim Investigational Site Fort Wayne Indiana
United States 1160.26.0315 Boehringer Ingelheim Investigational Site Fort Worth Texas
United States 1160.26.0444 Boehringer Ingelheim Investigational Site Fort Worth Texas
United States 1160.26.0428 Boehringer Ingelheim Investigational Site Fredericksburg Virginia
United States 1160.26.0145 Boehringer Ingelheim Investigational Site French Camp California
United States 1160.26.0333 Boehringer Ingelheim Investigational Site Fullerton California
United States 1160.26.0239 Boehringer Ingelheim Investigational Site Gainesville Florida
United States 1160.26.0045 Boehringer Ingelheim Investigational Site Garden City New York
United States 1160.26.0350 Boehringer Ingelheim Investigational Site Gastonia North Carolina
United States 1160.26.0062 Boehringer Ingelheim Investigational Site Germantown Tennessee
United States 1160.26.0236 Boehringer Ingelheim Investigational Site Glenview Illinois
United States 1160.26.0154 Boehringer Ingelheim Investigational Site Grand Blanc Michigan
United States 1160.26.0102 Boehringer Ingelheim Investigational Site Grand Forks North Dakota
United States 1160.26.0030 Boehringer Ingelheim Investigational Site Grand Rapids Michigan
United States 1160.26.0399 Boehringer Ingelheim Investigational Site Greeley Colorado
United States 1160.26.0234 Boehringer Ingelheim Investigational Site Green Bay Wisconsin
United States 1160.26.0322 Boehringer Ingelheim Investigational Site Greensboro North Carolina
United States 1160.26.0313 Boehringer Ingelheim Investigational Site Greenville South Carolina
United States 1160.26.0482 Boehringer Ingelheim Investigational Site Guilford Connecticut
United States 1160.26.0086 Boehringer Ingelheim Investigational Site Gulfport Mississippi
United States 1160.26.0244 Boehringer Ingelheim Investigational Site Haddon Heights New Jersey
United States 1160.26.0311 Boehringer Ingelheim Investigational Site Harrisonburg Virginia
United States 1160.26.0443 Boehringer Ingelheim Investigational Site Haverhill Massachusetts
United States 1160.26.0452 Boehringer Ingelheim Investigational Site Haverhill Massachusetts
United States 1160.26.0346 Boehringer Ingelheim Investigational Site Henderson Nevada
United States 1160.26.0294 Boehringer Ingelheim Investigational Site Hershey Pennsylvania
United States 1160.26.0173 Boehringer Ingelheim Investigational Site High Point North Carolina
United States 1160.26.0078 Boehringer Ingelheim Investigational Site Hillsboro Oregon
United States 1160.26.0396 Boehringer Ingelheim Investigational Site Hines Illinois
United States 1160.26.0260 Boehringer Ingelheim Investigational Site Hollywood Florida
United States 1160.26.0265 Boehringer Ingelheim Investigational Site Hollywood Florida
United States 1160.26.0038 Boehringer Ingelheim Investigational Site Hot Springs Arkansas
United States 1160.26.0447 Boehringer Ingelheim Investigational Site Houston Texas
United States 1160.26.0365 Boehringer Ingelheim Investigational Site Huntington West Virginia
United States 1160.26.0206 Boehringer Ingelheim Investigational Site Huntsville Alabama
United States 1160.26.0288 Boehringer Ingelheim Investigational Site Indianapolis Indiana
United States 1160.26.0352 Boehringer Ingelheim Investigational Site Indianapolis Indiana
United States 1160.26.0436 Boehringer Ingelheim Investigational Site Indianapolis Indiana
United States 1160.26.0100 Boehringer Ingelheim Investigational Site Inverness Florida
United States 1160.26.0033 Boehringer Ingelheim Investigational Site Jacksonville Florida
United States 1160.26.0089 Boehringer Ingelheim Investigational Site Jacksonville Florida
United States 1160.26.0232 Boehringer Ingelheim Investigational Site Jacksonville Florida
United States 1160.26.0240 Boehringer Ingelheim Investigational Site Jacksonville Florida
United States 1160.26.0427 Boehringer Ingelheim Investigational Site Jacksonville Florida
United States 1160.26.0464 Boehringer Ingelheim Investigational Site Jacksonville Florida
United States 1160.26.0209 Boehringer Ingelheim Investigational Site Jacksonville Beach Florida
United States 1160.26.0222 Boehringer Ingelheim Investigational Site Jamestown North Dakota
United States 1160.26.0028 Boehringer Ingelheim Investigational Site Jeffersonville Indiana
United States 1160.26.0369 Boehringer Ingelheim Investigational Site Jenkintown Pennsylvania
United States 1160.26.0303 Boehringer Ingelheim Investigational Site Jersey Shore Pennsylvania
United States 1160.26.0370 Boehringer Ingelheim Investigational Site Johnson City Tennessee
United States 1160.26.0302 Boehringer Ingelheim Investigational Site Jonesboro Arkansas
United States 1160.26.0171 Boehringer Ingelheim Investigational Site Kalamazoo Michigan
United States 1160.26.0027 Boehringer Ingelheim Investigational Site Kalispell Montana
United States 1160.26.0257 Boehringer Ingelheim Investigational Site Kansas City Missouri
United States 1160.26.0266 Boehringer Ingelheim Investigational Site Kansas City Missouri
United States 1160.26.0201 Boehringer Ingelheim Investigational Site Kettering Ohio
United States 1160.26.0483 Boehringer Ingelheim Investigational Site Killeen Texas
United States 1160.26.0251 Boehringer Ingelheim Investigational Site Kingston New York
United States 1160.26.0384 Boehringer Ingelheim Investigational Site La Jolla California
United States 1160.26.0091 Boehringer Ingelheim Investigational Site La Mesa California
United States 1160.26.0340 Boehringer Ingelheim Investigational Site Lacombe Louisiana
United States 1160.26.0018 Boehringer Ingelheim Investigational Site Lafayette Louisiana
United States 1160.26.0391 Boehringer Ingelheim Investigational Site Lafayette Louisiana
United States 1160.26.0104 Boehringer Ingelheim Investigational Site Lake Havasu City Arizona
United States 1160.26.0012 Boehringer Ingelheim Investigational Site Lakeland Florida
United States 1160.26.0246 Boehringer Ingelheim Investigational Site Lancaster California
United States 1160.26.0431 Boehringer Ingelheim Investigational Site Lancaster Pennsylvania
United States 1160.26.0168 Boehringer Ingelheim Investigational Site Langhorne Pennsylvania
United States 1160.26.0205 Boehringer Ingelheim Investigational Site Lapeer Michigan
United States 1160.26.0345 Boehringer Ingelheim Investigational Site Larkspur California
United States 1160.26.0066 Boehringer Ingelheim Investigational Site Las Vegas Nevada
United States 1160.26.0174 Boehringer Ingelheim Investigational Site Las Vegas Nevada
United States 1160.26.0430 Boehringer Ingelheim Investigational Site Las Vegas Nevada
United States 1160.26.0190 Boehringer Ingelheim Investigational Site Lebanon New Hampshire
United States 1160.26.0108 Boehringer Ingelheim Investigational Site Lexington North Carolina
United States 1160.26.0422 Boehringer Ingelheim Investigational Site Lexington Kentucky
United States 1160.26.0121 Boehringer Ingelheim Investigational Site Little Rock Arkansas
United States 1160.26.0191 Boehringer Ingelheim Investigational Site Little Rock Arkansas
United States 1160.26.0204 Boehringer Ingelheim Investigational Site Little Rock Arkansas
United States 1160.26.0213 Boehringer Ingelheim Investigational Site Little Rock Arkansas
United States 1160.26.0455 Boehringer Ingelheim Investigational Site Little Rock Arkansas
United States 1160.26.0217 Boehringer Ingelheim Investigational Site Loma Linda California
United States 1160.26.0223 Boehringer Ingelheim Investigational Site Lorain Ohio
United States 1160.26.0059 Boehringer Ingelheim Investigational Site Los Angeles California
United States 1160.26.0088 Boehringer Ingelheim Investigational Site Los Angeles California
United States 1160.26.0337 Boehringer Ingelheim Investigational Site Los Angeles California
United States 1160.26.0178 Boehringer Ingelheim Investigational Site Louisville Kentucky
United States 1160.26.0397 Boehringer Ingelheim Investigational Site Louisville Kentucky
United States 1160.26.0335 Boehringer Ingelheim Investigational Site Lubbock Texas
United States 1160.26.0214 Boehringer Ingelheim Investigational Site Lyndhurst Ohio
United States 1160.26.0099 Boehringer Ingelheim Investigational Site Madison Wisconsin
United States 1160.26.0242 Boehringer Ingelheim Investigational Site Madison Wisconsin
United States 1160.26.0359 Boehringer Ingelheim Investigational Site Marshfield Wisconsin
United States 1160.26.0326 Boehringer Ingelheim Investigational Site Mather California
United States 1160.26.0438 Boehringer Ingelheim Investigational Site Maywood Illinois
United States 1160.26.0230 Boehringer Ingelheim Investigational Site McKinney Texas
United States 1160.26.0293 Boehringer Ingelheim Investigational Site Meadowbrook Pennsylvania
United States 1160.26.0259 Boehringer Ingelheim Investigational Site Melbourne Florida
United States 1160.26.0358 Boehringer Ingelheim Investigational Site Melbourne Florida
United States 1160.26.0331 Boehringer Ingelheim Investigational Site Melrose Park Illinois
United States 1160.26.0070 Boehringer Ingelheim Investigational Site Merced California
United States 1160.26.0034 Boehringer Ingelheim Investigational Site Miami Florida
United States 1160.26.0199 Boehringer Ingelheim Investigational Site Miami Florida
United States 1160.26.0461 Boehringer Ingelheim Investigational Site Milwaukee Wisconsin
United States 1160.26.0229 Boehringer Ingelheim Investigational Site Mineola New York
United States 1160.26.0451 Boehringer Ingelheim Investigational Site Mineola New York
United States 1160.26.0131 Boehringer Ingelheim Investigational Site Minneapolis Minnesota
United States 1160.26.0421 Boehringer Ingelheim Investigational Site Minneapolis Minnesota
United States 1160.26.0115 Boehringer Ingelheim Investigational Site Mobile Alabama
United States 1160.26.0252 Boehringer Ingelheim Investigational Site Morgan City Louisiana
United States 1160.26.0450 Boehringer Ingelheim Investigational Site Mount Pleasant South Carolina
United States 1160.26.0279 Boehringer Ingelheim Investigational Site Muskegon Michigan
United States 1160.26.0323 Boehringer Ingelheim Investigational Site Nashville Tennessee
United States 1160.26.0395 Boehringer Ingelheim Investigational Site Nashville Tennessee
United States 1160.26.0029 Boehringer Ingelheim Investigational Site Natick Massachusetts
United States 1160.26.0243 Boehringer Ingelheim Investigational Site New Brunswick New Jersey
United States 1160.26.0090 Boehringer Ingelheim Investigational Site New Hyde Park New York
United States 1160.26.0132 Boehringer Ingelheim Investigational Site New Iberia Louisiana
United States 1160.26.0299 Tulane University School Of Medicine New Orleans Louisiana
United States 1160.26.0183 Boehringer Ingelheim Investigational Site New Rochelle New York
United States 1160.26.0316 Boehringer Ingelheim Investigational Site New York New York
United States 1160.26.0366 Boehringer Ingelheim Investigational Site Newark Delaware
United States 1160.26.0292 Boehringer Ingelheim Investigational Site Newport News Virginia
United States 1160.26.0025 Boehringer Ingelheim Investigational Site Newton Pennsylvania
United States 1160.26.0446 Boehringer Ingelheim Investigational Site Newtown Massachusetts
United States 1160.26.0224 Boehringer Ingelheim Investigational Site Norfolk Virginia
United States 1160.26.0364 Boehringer Ingelheim Investigational Site Normal Illinois
United States 1160.26.0394 Boehringer Ingelheim Investigational Site Norristown Pennsylvania
United States 1160.26.0109 Boehringer Ingelheim Investigational Site North Chicago Illinois
United States 1160.26.0003 Boehringer Ingelheim Investigational Site North Dartmouth Massachusetts
United States 1160.26.0146 Boehringer Ingelheim Investigational Site North Massapequa New York
United States 1160.26.0470 Boehringer Ingelheim Investigational Site Northborough Massachusetts
United States 1160.26.0210 Boehringer Ingelheim Investigational Site Northport New York
United States 1160.26.0152 Boehringer Ingelheim Investigational Site Oak Lawn Illinois
United States 1160.26.0474 Boehringer Ingelheim Investigational Site Oak Ridge Tennessee
United States 1160.26.0349 Boehringer Ingelheim Investigational Site Oakland California
United States 1160.26.0478 Boehringer Ingelheim Investigational Site Oakland New Jersey
United States 1160.26.0392 Boehringer Ingelheim Investigational Site Ocean City New Jersey
United States 1160.26.0016 Boehringer Ingelheim Investigational Site Oceanside California
United States 1160.26.0298 Boehringer Ingelheim Investigational Site Olympia Washington
United States 1160.26.0110 Boehringer Ingelheim Investigational Site Omaha Nebraska
United States 1160.26.0227 Boehringer Ingelheim Investigational Site Orlando Florida
United States 1160.26.0095 Boehringer Ingelheim Investigational Site Ormond Beach Florida
United States 1160.26.0310 Boehringer Ingelheim Investigational Site Owensboro Kentucky
United States 1160.26.0087 Boehringer Ingelheim Investigational Site Palm Springs California
United States 1160.26.0355 Boehringer Ingelheim Investigational Site Papillion Nebraska
United States 1160.26.0459 Boehringer Ingelheim Investigational Site Pasadena California
United States 1160.26.0472 Boehringer Ingelheim Investigational Site Paterson New Jersey
United States 1160.26.0212 Boehringer Ingelheim Investigational Site Pawtucket Rhode Island
United States 1160.26.0037 Boehringer Ingelheim Investigational Site Pensacola Florida
United States 1160.26.0076 Boehringer Ingelheim Investigational Site Pensacola Florida
United States 1160.26.0081 Boehringer Ingelheim Investigational Site Pensacola Florida
United States 1160.26.0111 Boehringer Ingelheim Investigational Site Pensacola Florida
United States 1160.26.0304 Boehringer Ingelheim Investigational Site Peoria Arizona
United States 1160.26.0445 Boehringer Ingelheim Investigational Site Petoskey Michigan
United States 1160.26.0158 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania
United States 1160.26.0181 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania
United States 1160.26.0416 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania
United States 1160.26.0006 Boehringer Ingelheim Investigational Site Pinehurst North Carolina
United States 1160.26.0344 Boehringer Ingelheim Investigational Site Pittsburgh Pennsylvania
United States 1160.26.0466 Boehringer Ingelheim Investigational Site Pittsburgh Pennsylvania
United States 1160.26.0467 Boehringer Ingelheim Investigational Site Plano Texas
United States 1160.26.0137 Boehringer Ingelheim Investigational Site Port Charlotte Florida
United States 1160.26.0389 Boehringer Ingelheim Investigational Site Port Charlotte Florida
United States 1160.26.0417 Boehringer Ingelheim Investigational Site Port Charlotte Florida
United States 1160.26.0245 Boehringer Ingelheim Investigational Site Portland Oregon
United States 1160.26.0075 Boehringer Ingelheim Investigational Site Poughkeepsie New York
United States 1160.26.0348 Boehringer Ingelheim Investigational Site Rapid City South Dakota
United States 1160.26.0216 Boehringer Ingelheim Investigational Site Redondo Beach California
United States 1160.26.0135 Boehringer Ingelheim Investigational Site Riverside California
United States 1160.26.0202 Boehringer Ingelheim Investigational Site Robbinsdale Minnesota
United States 1160.26.0197 Boehringer Ingelheim Investigational Site Rochester New York
United States 1160.26.0320 Boehringer Ingelheim Investigational Site Rochester New York
United States 1160.26.0274 Boehringer Ingelheim Investigational Site Rochester Hills Michigan
United States 1160.26.0198 Boehringer Ingelheim Investigational Site Rockford Illinois
United States 1160.26.0332 Boehringer Ingelheim Investigational Site Rockledge Florida
United States 1160.26.0177 Boehringer Ingelheim Investigational Site Rockville Maryland
United States 1160.26.0162 Boehringer Ingelheim Investigational Site Sacramento California
United States 1160.26.0300 Boehringer Ingelheim Investigational Site Sacramento California
United States 1160.26.0371 Boehringer Ingelheim Investigational Site Sacramento California
United States 1160.26.0226 Boehringer Ingelheim Investigational Site Safety Harbor Florida
United States 1160.26.0165 Boehringer Ingelheim Investigational Site Saginaw Michigan
United States 1160.26.0336 Boehringer Ingelheim Investigational Site Saint Charles Missouri
United States 1160.26.0249 Boehringer Ingelheim Investigational Site Saint Louis Missouri
United States 1160.26.0101 Boehringer Ingelheim Investigational Site Saint Paul Minnesota
United States 1160.26.0015 Boehringer Ingelheim Investigational Site Saint Petersburg Florida
United States 1160.26.0339 Boehringer Ingelheim Investigational Site Saint Petersburg Florida
United States 1160.26.0220 Boehringer Ingelheim Investigational Site Salem Virginia
United States 1160.26.0073 Boehringer Ingelheim Investigational Site Salisbury Maryland
United States 1160.26.0207 Boehringer Ingelheim Investigational Site Salisbury Maryland
United States 1160.26.0013 Boehringer Ingelheim Investigational Site San Antonio Texas
United States 1160.26.0269 Boehringer Ingelheim Investigational Site San Antonio Texas
United States 1160.26.0307 Boehringer Ingelheim Investigational Site San Antonio Texas
United States 1160.26.0116 Boehringer Ingelheim Investigational Site San Diego California
United States 1160.26.0148 Boehringer Ingelheim Investigational Site San Diego California
United States 1160.26.0270 Boehringer Ingelheim Investigational Site San Diego California
United States 1160.26.0284 Boehringer Ingelheim Investigational Site San Diego California
United States 1160.26.0285 Boehringer Ingelheim Investigational Site San Marcos Texas
United States 1160.26.0275 Boehringer Ingelheim Investigational Site Sandusky Ohio
United States 1160.26.0351 Boehringer Ingelheim Investigational Site Santa Ana California
United States 1160.26.0043 Boehringer Ingelheim Investigational Site Santa Rosa California
United States 1160.26.0031 Boehringer Ingelheim Investigational Site Sarasota Florida
United States 1160.26.0385 Boehringer Ingelheim Investigational Site Sarasota Florida
United States 1160.26.0068 Boehringer Ingelheim Investigational Site Scarborough Maine
United States 1160.26.0064 Boehringer Ingelheim Investigational Site Scarsdale New York
United States 1160.26.0208 Boehringer Ingelheim Investigational Site Sellersville Pennsylvania
United States 1160.26.0048 Boehringer Ingelheim Investigational Site Shreveport Louisiana
United States 1160.26.0235 Boehringer Ingelheim Investigational Site South Bend Indiana
United States 1160.26.0166 Boehringer Ingelheim Investigational Site Spartanburg South Carolina
United States 1160.26.0250 Boehringer Ingelheim Investigational Site Spokane Washington
United States 1160.26.0133 Boehringer Ingelheim Investigational Site Springfield Oregon
United States 1160.26.0002 Boehringer Ingelheim Investigational Site Statesville North Carolina
United States 1160.26.0069 Boehringer Ingelheim Investigational Site Statesville North Carolina
United States 1160.26.0010 Boehringer Ingelheim Investigational Site Stuart Florida
United States 1160.26.0008 Boehringer Ingelheim Investigational Site Summerville South Carolina
United States 1160.26.0462 Boehringer Ingelheim Investigational Site Sylmar California
United States 1160.26.0256 Boehringer Ingelheim Investigational Site Tacoma Washington
United States 1160.26.0196 Boehringer Ingelheim Investigational Site Takoma Park Maryland
United States 1160.26.0327 Boehringer Ingelheim Investigational Site Tamarac Florida
United States 1160.26.0271 Boehringer Ingelheim Investigational Site Tampa Florida
United States 1160.26.0328 Boehringer Ingelheim Investigational Site Tampa Florida
United States 1160.26.0381 Boehringer Ingelheim Investigational Site Tampa Florida
United States 1160.26.0276 Boehringer Ingelheim Investigational Site Torrance California
United States 1160.26.0187 Boehringer Ingelheim Investigational Site Towson Maryland
United States 1160.26.0020 Boehringer Ingelheim Investigational Site Troy Michigan
United States 1160.26.0414 Boehringer Ingelheim Investigational Site Troy New York
United States 1160.26.0185 Boehringer Ingelheim Investigational Site Tucson Arizona
United States 1160.26.0305 Boehringer Ingelheim Investigational Site Tucson Arizona
United States 1160.26.0435 Boehringer Ingelheim Investigational Site Tulsa Oklahoma
United States 1160.26.0119 Boehringer Ingelheim Investigational Site Tupelo Mississippi
United States 1160.26.0215 Boehringer Ingelheim Investigational Site Tyler Texas
United States 1160.26.0367 Boehringer Ingelheim Investigational Site Tyler Texas
United States 1160.26.0465 Boehringer Ingelheim Investigational Site Uniontown Pennsylvania
United States 1160.26.0400 Boehringer Ingelheim Investigational Site Upland Pennsylvania
United States 1160.26.0019 Boehringer Ingelheim Investigational Site Vero Beach Florida
United States 1160.26.0221 Boehringer Ingelheim Investigational Site Voorhees New Jersey
United States 1160.26.0379 Boehringer Ingelheim Investigational Site Walnut Creek California
United States 1160.26.0343 Boehringer Ingelheim Investigational Site Washington District of Columbia
United States 1160.26.0356 Boehringer Ingelheim Investigational Site Watertown New York
United States 1160.26.0024 Boehringer Ingelheim Investigational Site Wenatchee Washington
United States 1160.26.0468 Boehringer Ingelheim Investigational Site West Columbia South Carolina
United States 1160.26.0001 Boehringer Ingelheim Investigational Site West Des Moines Iowa
United States 1160.26.0189 Boehringer Ingelheim Investigational Site West Des Moines Iowa
United States 1160.26.0357 Boehringer Ingelheim Investigational Site West Des Moines Iowa
United States 1160.26.0103 Boehringer Ingelheim Investigational Site Westlake Ohio
United States 1160.26.0052 Boehringer Ingelheim Investigational Site Westminster Maryland
United States 1160.26.0254 Boehringer Ingelheim Investigational Site Westwood New Jersey
United States 1160.26.0354 Boehringer Ingelheim Investigational Site Wichita Kansas
United States 1160.26.0039 Boehringer Ingelheim Investigational Site Williamsville New York
United States 1160.26.0372 Boehringer Ingelheim Investigational Site Wilmington North Carolina
United States 1160.26.0317 Boehringer Ingelheim Investigational Site Winchester Virginia
United States 1160.26.0433 Boehringer Ingelheim Investigational Site Winfield Illinois
United States 1160.26.0094 Boehringer Ingelheim Investigational Site Winston-Salem North Carolina
United States 1160.26.0425 Boehringer Ingelheim Investigational Site Winston-Salem North Carolina
United States 1160.26.0308 Boehringer Ingelheim Investigational Site Worcester Massachusetts
United States 1160.26.0032 Boehringer Ingelheim Investigational Site Wynnewood Pennsylvania
United States 1160.26.0067 Boehringer Ingelheim Investigational Site Wyomissing Pennsylvania
United States 1160.26.0188 Boehringer Ingelheim Investigational Site Ypsilanti Michigan

Sponsors (3)

Lead Sponsor Collaborator
Boehringer Ingelheim Population Health Research Institute, Uppsala University

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Austria,  Belgium,  Brazil,  Bulgaria,  Canada,  China,  Colombia,  Czechia,  Denmark,  Finland,  France,  Germany,  Greece,  Hong Kong,  Hungary,  India,  Israel,  Italy,  Japan,  Korea, Republic of,  Malaysia,  Mexico,  Netherlands,  Norway,  Peru,  Philippines,  Poland,  Portugal,  Romania,  Russian Federation,  Singapore,  Slovakia,  South Africa,  Spain,  Sweden,  Switzerland,  Taiwan,  Thailand,  Turkey,  Ukraine,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Yearly Event Rate for Composite Endpoint of Stroke/SEE Time to first occurrence of stroke or systemic embolic event. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25 36 months
Secondary Yearly Event Rate for Composite Endpoint of Stroke/SEE/All Cause Death Time to first occurrence of stroke, SEE or all cause death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25 36 months
Secondary Yearly Event Rate: Composite of Stroke/SEE/PE/MI/Vascular Death Time to first occurrence of stroke, systemic embolic event, pulmonary embolism, myocardial infarction including silent myocardial infarction or vascular death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25 36 months
Secondary Bleeding Events (Major and Minor) Yearly event rate of bleeds. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25
Major bleeds are adjudicated, whereas minor bleeds are investigator reported.
36 months
Secondary Clinical Relevant Abnormalities for Intracerebral Hemorrhage and Other Intracranial Hemorrhage (ICH) Patients with clinical relevant abnormalities for intracerebral hemorrhage, other intracranial hemorrhage (ICH) 36 months
Secondary Abnormal Liver Function Test Number of subjects with abnormal liver function test (LFT), i.e., ALT/AST>3xULN and total bilirubin > 2 x ULN 36 months
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Recruiting NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Active, not recruiting NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05621980 - Finger Movement Training After Stroke N/A